Nigeria has joined the league of covid-19 producers after some Nigerian Scientists successfully produced two COVID-19 vaccines .
The Secretary to the Government of the Federation and Chairman of the covid task force, Boss Mustapha, who announced the breakthrough on Monday said vaccines are currently awaiting clinical trials and certification
The disclosure that Nigerian Scientists have produced at least two (2) local COVID-19 vaccines which are awaiting clinical trials and certification is significant. I call on all relevant agencies to provide the required support and enabling environment for smooth conduct of the remaining protocols for the certification of these vaccines with a view to encouraging and motivating other researchers,” Mustapha said
“Last week, we visited Ebonyi, Enugu, Anambra & Delta states to commisison new laboratories, visit PHEOCs & health workers on the frontlines. We’ll continue to support all States to build their resilience, as the goal is for stronger health security in Nigeria.”
About 122,410 Nigerians have received jabs of the Oxford-AstraZeneca COVID-19 vaccine, the Executive Director of the National Primary Health Care Development Agency (NPHCDA), Faisal Shuaib, said on Monday.
Mr Shuaib while speaking at the weekly briefing of the Presidential Task Force (PTF) on COVID-19 said Nigeria has not recorded any serious adverse reaction following the administration of the Oxford-AstraZeneca COVID-19 vaccines.
“So far, 122,410 people have been vaccinated with Oxford Astrazeneca vaccine in Nigeria,” he said
“No Nigerian so far has developed any known severe side effect, while we have observed that there might be some mild symptoms like pain and swelling at the site of the vaccination, body pains and mild fever.”
He explained that one can take the vaccine and have other diseases that are completely unrelated to the vaccination process.
Mr Faisal noted that the agency will continue to collaborate with the NAFDAC ‘pharmacovigilance team’ to monitor the administration of the vaccine and document any adverse reactions.
This, he said, is to assure Nigerians that the government is honest and transparent in its choice of the vaccine to protect the citizens against the virus which has claimed over 2,000 lives in the country.
Nigeria in early March received 3.94 million doses of the Oxford-AstraZeneca vaccine through the COVAX facility, led by the World Health Organisation, and has commenced vaccination beginning with healthcare workers and other provides of essential services.
The country also received 300,000 doses of the Oxford-AstraZeneca COVID-19 vaccines from telecom giant, MTN, on Sunday, according to the Chairman of PTF on COVID-19, Boss Mustapha.
09054006557 Text/Call firstname.lastname@example.org